Evidence map›Paper›PMID 40978695›Full record

ArticleFrontiers in digital health2025

Neural network analysis of the contribution of psychotropic prescription sequences to the risk of non-psychiatric adverse events in bipolar and schizophrenia spectrum disorders.

Nathan Vidal, Mohammed Sedki, Nadia Younès, Hugo Bottemanne, Paul Roux, Eric Brunet-Gouet

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathan VidalCentre Hospitalier de Versailles, Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Le Chesnay, France.
Mohammed SedkiOncoStat Team, INSERM UMR1018, CESP, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Nadia YounèsCentre Hospitalier de Versailles, Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Le Chesnay, France.
Hugo BottemanneMOODS team, INSERM UMR1018, CESP, Faculté de Médecine Paris-Saclay, Université de Versailles Saint-Quentin-En-Yvelines, Université Paris-Saclay, Villejuif, France.
Paul RouxCentre Hospitalier de Versailles, Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Le Chesnay, France.
Eric Brunet-GouetCentre Hospitalier de Versailles, Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Le Chesnay, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychotropic medications are associated with lower mortality in bipolar disorders (BD) and schizophrenia spectrum disorders (SZD) but may trigger serious adverse events requiring hospitalization. Determining the iatrogenic causes of such events can considerably help psychiatrists understand their development and adjust the prescription accordingly. We aimed to assess to what extent the psychotropic prescription sequence contributes to in-hospital non-psychiatric adverse events in BD and SZD. We conducted a case-control design including adults with BD or SZD from the French national healthcare system claims database (

Indexed as

adverse drug eventbipolar disorderspsychotropic adverse effectspsychotropic drugsschizophrenia

Identifiers

PMID40978695
PMCPMC12443787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.